68% of Healthcare Workers Believe Needlestick Injuries Remain a Problem According to a MedPro Survey

Company to Conduct a Second Survey at Upcoming ASHP Conference

Lexington, KY – December 5, 2011 – MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, surveyed 262 healthcare professionals at the APIC 2011 Annual Educational Conference held in June 2011.The survey’s key findings include:

• 68% of healthcare workers do not believe that syringe needlestick injuries have been eliminated at their institutions, despite FDA, CDC, and OSHA requirements in place for more than a decade.
• 43% do not believe the safety features that prevent needlestick injury are always activated after use and prior to disposal at their institutions, and less than 40% check for activation.
• 43% are not happy or ambivalent with the current syringes used at their institutions.

These findings indicate a high degree of concern among healthcare professionals about the risk of needlestick injuries from the syringes currently used by their institutions. Survey questions also focused on brands, pricing and other features, including ease of use.  MedPro’s blood collection product line offers a passive safety mechanism that is automatically activated, allowing clinicians to deploy it safely without adding steps to the procedure.

MedPro develops safer medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) systems. Unlike competitive safety needle products currently on the market, MedPro’s safety features operate without user activation, and therefore require little or no clinician training to use.

“We gathered helpful insights from the survey of healthcare professionals at APIC,” said Bethany Denning, Director of Corporate Relations for MedPro Safety Products.  “Our survey at ASHP will help us learn more from pharmacists and has been structured to provide additional information on issues of specific concern to these important professionals, including the benefits of prefilled drug delivery systems. We look forward to reviewing and being guided by the results.”

ASHP Conference

The Company will conduct a second survey at its Booth #1924 at the American Society of Health-System Pharmacists (ASHP) Midyear 2011 Clinical Meeting and Exhibition, December 4 through 8 in New Orleans, Louisiana.  The survey will solicit pharmacists’ views of drug development and delivery, and how packaging issues impact workflow and patient safety. The survey will also focus on potential improvements to existing prefilled syringes and needlestick prevention technology.

About MedPro Safety Products, Inc.
Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems.  The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners. MedPro’s products address multiple product categories within the medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets.  Unlike competitive products currently available on the market, MedPro’s products incorporate safety features that operate without user activation, and therefore require little or no clinician training to use.  The total global market opportunity for safer medication delivery and blood collection products is believed to be more than $6 billion.  For additional information, please refer to the ‘Investor Relations’ link on the Company’s website (www.medprosafety.com).

Contact Information:

Investor Contact:
Doug Sherk/Jenifer Kirtland
EVC Group

Media Contact:
Christopher Gale
EVC Group